Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications

    Pharmacognosy Communications, Vol 14, Issue 4, Oct-Dec 2024

    Published: 20 November 2024 Upcoming Events

    Upcoming Events

    Pharmacognosy Communications, 14 (4), 2024, 189-189.
    DOI:
    Read Full Text PDF
    Published: 18 November 2024 Medicinal Plant Images

    Medicinal Plant Images

    Ian E Cock
    Pharmacognosy Communications, 14 (4), 2024, 187-188.
    DOI: 10.5530/pc.2024.4.29
    Read Full Text PDF
    Published: 18 November 2024 The Janus Corner

    The Venom of One of the World’s Most Deadly Spiders may Provide a Novel Drug to Treat Heart Attack and Stroke Patients and Save Lives

    Ian E Cock
    Pharmacognosy Communications, 14 (4), 2024, 185-186.
    DOI: 10.5530/pc.2024.4.28
    Read Full Text PDF
    Published: 18 November 2024 Original Article

    Hamamelis virginiana L. Leaf Extracts Inhibit Some Bacterial Triggers of Selected Autoimmune Inflammatory Diseases

    Cindy Nguyen, Ian Edwin Cock
    Pharmacognosy Communications, 14 (4), 2024, 175-184.
    DOI: 10.5530/pc.2024.4.27
    Read Full Text PDF
    Published: 18 November 2024 Original Article

    Tasmannia lanceolata (Poir.) A.C. Sm. Berry Extracts Inhibit the Growth of the Skin Pathogens Staphylococcus aureus and Staphylococcus epidermidis

    Ian Edwin Cock, Veronica Winnett
    Pharmacognosy Communications, 14 (4), 2024, 168-174.
    DOI: 10.5530/pc.2024.4.26
    Read Full Text PDF
    Published: 18 November 2024 Original Article

    Terminalia bellericia (Gaertn.) Roxb. Fruit Extracts Inhibit the Growth of Bacterial Triggers of Selected Autoimmune Inflammatory Diseases and Potentiate the Activity of Conventional Antibiotics

    Ian Edwin Cock, Kun Wang, Mengqi Xiao
    Pharmacognosy Communications, 14 (4), 2024, 155-167.
    DOI: 10.5530/pc.2024.4.25
    Read Full Text PDF
    Published: 18 November 2024 Original Article

    Interactive Antibacterial Activity and Toxicity Profiles of Selected Pure Plant Compounds and Conventional Antibiotics Against Bacterial Triggers of Some Autoimmune Diseases

    Audric Puisais, Ian Edwin Cock
    Pharmacognosy Communications,, 14 (4), 2024, 144-154.
    DOI: 10.5530/pc.2024.4.24
    Read Full Text PDF
    Published: 18 November 2024 Original Article

    Assessment of the Phytochemical Composition and Antioxidant Properties of Ripe Fruit of Cucumis metuliferus E. Meyer Ex. Naudin

    Ishaku Leo Elisha, Joy Gararawa Usman, Monday Michael Onakpa, Olatunde Peter Ajagbonna, Saka Sanni, Usman Ngamarju Gadzama
    Pharmacognosy Communications, 14 (4), 2024, 138-143.
    DOI: 10.5530/pc.2024.4.23
    Read Full Text PDF
    Published: 18 November 2024

    Editorial

    Ian E Cock
    Pharmacognosy Communications, 14 (4), 2024, 137.
    DOI: 10.5530/pc.2024.4.22
    Read Full Text PDF
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up